ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Acetone → 2-[2-(Trifluoromethyl)-6-({4-[1-(trifluoromethyl)cyclopropyl]phenyl}sulfonyl)-6,11-dihydro-5H-pyrido[2,3-b][1,5]benzodiazepin-8-yl]propan-2-ol

HRID 1691464
印刷

反応式

HRID 1691464 の反応式
IC1[CH:3]=[CH:4][C:5]2[NH:11][C:10]3[N:12]=[C:13]([C:16]([F:19])([F:18])[F:17])[CH:14]=[CH:15][C:9]=3[CH2:8][N:7]([S:20]([C:23]3[CH:28]=[CH:27][C:26]([C:29]4([C:32]([F:35])([F:34])[F:33])[CH2:31][CH2:30]4)=[CH:25][CH:24]=3)(=[O:22])=[O:21])[C:6]=2[CH:36]=1.[CH:37]([Mg]Br)(C)C.[CH3:42][C:43]([CH3:45])=[O:44]>C1COCC1.CCOCC>[F:18][C:16]([F:17])([F:19])[C:13]1[CH:14]=[CH:15][C:9]2[CH2:8][N:7]([S:20]([C:23]3[CH:24]=[CH:25][C:26]([C:29]4([C:32]([F:35])([F:34])[F:33])[CH2:31][CH2:30]4)=[CH:27][CH:28]=3)(=[O:21])=[O:22])[C:6]3[CH:36]=[C:42]([C:43]([OH:44])([CH3:37])[CH3:45])[CH:3]=[CH:4][C:5]=3[NH:11][C:10]=2[N:12]=1
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

6

反応物 3

HCID 180AcetoneHCID 866490398-Iodo-2-(trifluoromethyl)-6-({4-[1-(trifluoromethyl)cyclopropyl]phenyl}sulfonyl)-6,11-dihydro-5H-pyrido[2,3-b][1,5]benzodiazepine2 回HCID 178418365HCID 178418365、化合物

生成物 1

HCID 596187832-[2-(Trifluoromethyl)-6-({4-[1-(trifluoromethyl)cyclopropyl]phenyl}sulfonyl)-6,11-dihydro-5H-pyrido[2,3-b][1,5]benzodiazepin-8-yl]propan-2-ol

試薬・触媒・溶媒 2

HCID 3283
Diethyl Ether
溶媒
HCID 8028Tetrahydrofuran溶媒

反応条件

温度
0 °C

実験手順

To a solution of 8-iodo-2-(trifluoromethyl)-6-({4-[1-(trifluoromethyl)-cyclopropyl]phenyl}sulfonyl)-6,11-dihydro-5H-pyrido[2,3-b][1,5]benzodiazepine (intermediate 59, 150 mg, 0.235 mmol) in THF (1.5 mL) at 0° C. was added isopropylmagnesium bromide (1.89 mmol of a 2M solution in ether). After stirred at 0° C. for 40 min, acetone (204 mg, 3.52 mmol) was added dropwise and the reaction mixture was gradually brought to rt. The reaction was quenched with saturated aqueous NH4Cl and diluted with EtOAc. The organic layer was separated and the aqueous phase was extracted with EtOAc. The combined extracts were washed with water, brine, dried over MgSO4 and concentrated. Purification of the residue via SiO2 column chromatography provided the title compound. LC/MS: m/e 572.0 (M+H)+. 1H NMR (500 MHz, CDCl3): δ 7.65 (1H, d, J=2.1 Hz), 7.56 (1H, d, J=7.5 Hz), 7.44 (1H, dd, J=8.5, 1.6 Hz), 7.21 (2H, d, J=8.3 Hz), 7.05 (1H, d, J=7.3 Hz), 7.02 (2H, d, J=8.5 Hz), 6.77 (1H, s), 6.74 (1H, J=8.2 Hz), 4.70-4.90 (2H, s, br), 1.64 (6H, s), 1.35-1.42 (4H, m), 1.26-1.30 (4H, m).

後処理

  1. customwas gradually brought to rt
  2. customThe reaction was quenched with saturated aqueous NH4Cl
  3. additiondiluted with EtOAc
  4. customThe organic layer was separated
  5. extractionthe aqueous phase was extracted with EtOAc
  6. washThe combined extracts were washed with water, brine
  7. dry with materialdried over MgSO4
  8. concentrationconcentrated
  9. customPurification of the residue via SiO2 column chromatography

出典と根拠

ORDレコード
ord-ad1f970cf627463082f9225133935bdf
出典データセット
uspto-grants-2012_04
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08153626B2

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート